<DOC>
	<DOCNO>NCT00300924</DOCNO>
	<brief_summary>The purpose study test experimental drug combination two medication currently approve Food Drug Administration ( FDA ) migraine headache pain . These call rizatriptan give acetaminophen .</brief_summary>
	<brief_title>A Study Rizatriptan Co-Administered With Acetaminophen Treatment Acute Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Rizatriptan</mesh_term>
	<criteria>Subject least 18 year age Subject least 6 month history migraine , without aura Subject distinguish migraine attack type headache Subject childbearing potential agrees use adequate contraception Subject typically few 1 great 6 migraine attack per month Subject typically great 10 headache day per month Subject evidence ischemic heart disease Subject uncontrolled high blood pressure Subject history , within 1 year , current evidence drug alcohol abuse *This list inclusive*</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>